SAN LEANDRO, Calif., June 18, 2013 /PRNewswire/ -- Cataracts are the leading cause of blindness in the world. According to the American Association of Ophthalmology, aging is the leading cause of eye diseases such as cataracts, a clouding of the eye's natural lens. 22 million Americans age 40 and older have cataracts, and by 2020, as Baby Boomers continue to age, that number will increase over 30 million. In a fast moving, high tech world of iPhones, iPads, smart-phones and computers, the demographic of ages 40 plus works later in life, the daily eye strain and acuity of mid vision and astigmatism becomes more and more critical.
The newly FDA-approved TRULIGN™ Toric Intraocular Lens is the first ever Toric IOL that corrects astigmatism and, unlike other standard Toric lenses, has the additional capacity to improve vision across a natural range of focus. It can also reduce a patient's need to wear glasses for day-to-day activities, all in a single procedure. This is quite a package of potential benefits for today's (and tomorrow's) cataract patient who leads an active lifestyle.
In the FDA clinical trials, the TRULIGN™ Toric was shown to be exceptionally stable in correction of astigmatism and improved near, intermediate and distance vision.
Dr. Nicholas Batra, Cornea Specialist and Medical Director of BatraVision Medical Group in San Leandro, California, is one of only a handful of ophthalmologists in the US who has the new TRULIGN™ Toric IOL, and the only surgeon in California offering this exciting new technology to his patients. During cataract surgery Dr. Batra uses the revolutionary ORA System™, an innovative technology that allows him to see pictures of the eye in real time on a monitor, throughout the surgery. This ensures the precise prescription IOL was selected.
About TRULIGN™ Toric
The TRULIGN™ Toric posterior chamber intraocular lens is intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia and postoperative refractive astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia who desire reduction of residual refractive cylinder with increased spectacle independence and improved uncorrected near, intermediate and distance vision.
About Cataract Surgery
Cataract surgery is a simple procedure during which the natural lens is surgically replaced with an IOL, an intraocular lens. 99.5% of all patients report no complications.
Astigmatism occurs due to the irregular shape of the cornea or the lens inside the eye. The cornea and lens are primarily responsible for focusing light entering your eyes allowing you to see things clearly. With astigmatism, the surface of the cornea or lens has a different curvature in one direction than another. In the case of the cornea, instead of having a round shape like a basketball, the surface of the cornea is more like a football. As a result, the eye is unable to focus light rays to a single point causing vision to be out of focus at any distance.
About Dr. Batra
Dr. Batra attended Dartmouth; he was awarded his Doctorate of Medicine at the University of California, Los Angeles (UCLA), and completed his ophthalmology residency at the University at of California, San Francisco. Dr. Batra received a fellowship from UCSF/Proctor Foundation in Cornea and Refractive surgery, and he received a Fellowship with the prestigious Heed Foundation.
Contact Linda Zanides:
Zanides Public Relations
|SOURCE Batravision Medical Group|
Copyright©2012 PR Newswire.
All rights reserved